AR050345A1 - METHODS TO TREAT SUBSTANCE RELATED DISORDERS - Google Patents
METHODS TO TREAT SUBSTANCE RELATED DISORDERSInfo
- Publication number
- AR050345A1 AR050345A1 ARP050102683A AR050345A1 AR 050345 A1 AR050345 A1 AR 050345A1 AR P050102683 A ARP050102683 A AR P050102683A AR 050345 A1 AR050345 A1 AR 050345A1
- Authority
- AR
- Argentina
- Prior art keywords
- substance
- treatment
- group
- compounds
- phenyl
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Método para la prevencion, tratamiento o mejora de trastornos relacionados con sustancias, en un sujeto que lo necesite y comprende la administracion al sujeto de una cantidad efectiva de un compuesto seleccionado de los compuestos de formula (1) o (2), o sus formas farmacéuticamente aceptadas donde el fenilo se sustituye en X por 1 a 5 átomos de halogeno seleccionados del grupo formado por fluor, cloro, bromo y yodo; y R1, R2, R3, R4, R5 y R6 se seleccionan de manera independiente del grupo formado por hidrogeno y alquilo C1-4; donde alquilo C1-4 se sustituye opcionalmente por fenilo (y, donde el fenilo se sustituye opcionalmente por sustituyentes independientemente seleccionados del grupo formado por halogeno, alquilo C1-4, alcoxi C1- 4, amino, nitro y ciano). Además, los métodos incluidos comprenden la co-administracion de los compuestos de la presente con uno o más compuestos conocidos para el tratamiento de trastornos inducidos por sustancias. Reivindicacion 11: El método de la reivindicacion 1, donde el método también comprende la prevencion, tratamiento y mejora de un trastorno inducido por sustancias que resulta del uso de una droga adictiva. Reivindicacion 12: El método de la reivindicacion 11, donde la droga adictiva se selecciona de heroína, opio, morfina, cocaína, anfetaminas, metanfetaminas, etanol, benzodiazepinas, metadona, oxicodona, codeina, inhalantes, barbituricos, fenciclidinas o nicotina. Reivindicacion 16: El método de la reivindicacion 14, donde el compuesto conocido para el tratamiento de trastornos inducidos por sustancias es uno o más compuestos seleccionados del grupo formado por acamprosato, naltrexona, naloxona y disulfiram.Method for the prevention, treatment or improvement of substance-related disorders, in a subject in need and comprising administering to the subject an effective amount of a compound selected from the compounds of formula (1) or (2), or their forms pharmaceutically accepted where the phenyl is substituted in X by 1 to 5 halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-4 alkyl; wherein C1-4 alkyl is optionally substituted by phenyl (and, where the phenyl is optionally substituted by substituents independently selected from the group consisting of halogen, C1-4 alkyl, C1-4 alkoxy, amino, nitro and cyano). In addition, the included methods comprise co-administration of the compounds herein with one or more known compounds for the treatment of substance induced disorders. Claim 11: The method of claim 1, wherein the method also comprises the prevention, treatment and improvement of a substance-induced disorder resulting from the use of an addictive drug. Claim 12: The method of claim 11, wherein the addictive drug is selected from heroin, opium, morphine, cocaine, amphetamines, methamphetamines, ethanol, benzodiazepines, methadone, oxycodone, codeine, inhalants, barbiturates, phencyclidines or nicotine. Claim 16: The method of claim 14, wherein the compound known for the treatment of substance-induced disorders is one or more compounds selected from the group consisting of acamprosate, naltrexone, naloxone and disulfiram.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58419104P | 2004-06-30 | 2004-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR050345A1 true AR050345A1 (en) | 2006-10-18 |
Family
ID=37311740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102683 AR050345A1 (en) | 2004-06-30 | 2005-06-29 | METHODS TO TREAT SUBSTANCE RELATED DISORDERS |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR050345A1 (en) |
| MY (1) | MY149385A (en) |
| PE (1) | PE20060559A1 (en) |
-
2005
- 2005-06-27 PE PE2005000743A patent/PE20060559A1/en not_active Application Discontinuation
- 2005-06-28 MY MYPI20052946 patent/MY149385A/en unknown
- 2005-06-29 AR ARP050102683 patent/AR050345A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20060559A1 (en) | 2006-08-11 |
| MY149385A (en) | 2013-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003106428A8 (en) | Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists | |
| TW200621249A (en) | Substituted amide beta secretase inhibitors | |
| TW200607807A (en) | Macrocyclic beta-secretase inhibitors | |
| BRPI0520451A2 (en) | methods for treating chemical disorders | |
| WO2005047279A8 (en) | Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain | |
| ATE360633T1 (en) | N-SUBSTITUTED HYDROMORPHONES AND THEIR APPLICATION | |
| CA2609733A1 (en) | 6,7-unsaturated-7-carbamoyl-substituted morphinan derivative | |
| NO20055655D0 (en) | Use of azetidinecarboxamide derivatives in therapy | |
| RU2007116987A (en) | NEW COMPOUNDS | |
| DE69838662D1 (en) | Morphine derivatives and their medical use | |
| AR035756A1 (en) | USE OF CARBAMATES IN THE PREPARATION OF MEDICINES FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| BRPI0512086A (en) | compound and the pharmaceutically acceptable salts thereof, pharmaceutical composition, and process for the preparation of compounds | |
| AR033426A1 (en) | USE OF CARBAMATE COMPOUNDS IN THE PREVENTION OR TREATMENT OF MOVEMENT DISORDERS | |
| RU2003128984A (en) | CARBAMATE DERIVATIVES FOR USE FOR TREATMENT OF PAIN | |
| ATE287397T1 (en) | CHINOLINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS | |
| PT1399144E (en) | CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF ANXIETY DISTURBANCES | |
| AR050345A1 (en) | METHODS TO TREAT SUBSTANCE RELATED DISORDERS | |
| DE60134735D1 (en) | NEW NEUROKININ ANTAGONISTS FOR USE AS DRUGS | |
| GEP201606538B (en) | Preoperative treatment of post operative pain | |
| EP1699466A4 (en) | New compounds useful as metal chelators | |
| ATE375353T1 (en) | THIENOPYRIDONE CARBONIC ACID AMIDES AND THEIR MEDICAL USE | |
| WO2001046198A3 (en) | Nonpeptide kappa opioid receptor antagonists | |
| WO2003096992A3 (en) | Treatment of cancer with mefloquire | |
| EP1172106A3 (en) | Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists | |
| DK1011672T3 (en) | Use of (E) -methanicotine derivatives to produce analgesic effects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |